Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)
Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)
Active, not recruiting · NCT07849660 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Not stated | 2026-09-30 | NCT07849660 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Inc. | 40 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eisai Trial Site #1 | Nutley | United States | 5 |